Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
Titel:
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer
Auteur:
Ocean, Allyson J. Christos, Paul Sparano, Joseph A. Matulich, Dan Kaubish, Andreas Siegel, Abby Sung, Max Ward, Maureen M. Hamel, Nancy Espinoza-Delgado, Igor Yen, Yun Lane, Maureen E.